Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets close in 1 hour 40 minutes
FTSE 100
8,440.95
+59.60
(+0.71%)
FTSE 250
20,680.82
+149.52
(+0.73%)
AIM
789.51
+5.81
(+0.74%)
GBP/EUR
1.1619
+0.0008
(+0.07%)
GBP/USD
1.2538
+0.0014
(+0.11%)
Bitcoin GBP
50,276.71
+1,524.48
(+3.13%)
PROPERTY
Homes with investment potential
These residential properties could bring in a good ROI
Protalix BioTherapeutics Inc (PBDA.DU)
Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
1.1860
+0.1090
(+10.12%)
As of 09:10AM CEST. Market open.
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
65,494
65,494
47,638
38,350
62,898
Cost of revenue
22,982
22,982
19,592
16,349
10,873
Gross profit
42,512
42,512
28,046
22,001
52,025
Operating expenses
Research development
17,093
17,093
29,349
29,734
38,167
Selling general and administrative
14,959
14,959
11,711
12,729
11,148
Total operating expenses
32,052
32,052
41,060
42,463
49,315
Operating income or loss
10,460
10,460
-13,014
-20,462
2,710
Interest expense
3,180
3,180
2,529
7,521
9,671
Income before tax
8,566
8,566
-14,397
-27,582
-6,523
Income tax expense
254
254
530
0
-
Income from continuing operations
8,312
8,312
-14,927
-27,582
-6,523
Net income
8,312
8,312
-14,927
-27,582
-6,523
Net income available to common shareholders
8,312
8,312
-14,927
-27,582
-6,523
Basic EPS
-0.62
0.12
-0.31
-0.62
-0.22
Diluted EPS
-0.62
0.09
-0.31
-0.62
-0.22
Basic average shares
44,140
67,513
48,472
44,140
29,148
Diluted average shares
44,140
82,424
48,472
44,140
29,148
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.